Collaborators
The Hospital for Sick Children (SickKids),
TORONTO
Canada’s most research-intensive hospital. Preclinical NEC and BPD studies.
Great Ormond Street Hospital and the UCL Institute of Child Health
London
an eight-year collaboration on preclinical studies and clinical trial preparation. Micregen and UCL hold an MRC grant part-funding a PhD programme on Secretomix® in NEC, led by Dr Stavros Loukogeorgakis with Dr Jay Sivaraj.
THE UNIVERSITY OF BRADFORD
BRADFORD
validation of Secretomix® in models of neurodegeneration.
Washington University School of Medicine
ST. LOUIS, USA
research into bronchopulmonary dysplasia and neonatal lung indications.
University of Reading
ST. LOUIS, USA
foundational secretome research and early efficacy studies across multiple tissue models, establishing the biology on which Secretomix® is built. Led by Prof. Ketan Patel.
Get in touch with us